S&P 500   2,749.98 (+3.41%)
DOW   23,433.57 (+3.44%)
QQQ   200.57 (+2.12%)
AAPL   266.07 (+2.56%)
FB   174.28 (+3.23%)
MSFT   165.13 (+1.00%)
GOOGL   1,207.00 (+2.07%)
AMZN   2,043.00 (+1.56%)
CGC   14.83 (+2.28%)
NVDA   266.95 (+3.06%)
BABA   195.98 (-1.02%)
MU   48.29 (+3.76%)
GE   7.30 (+3.84%)
TSLA   548.84 (+0.62%)
AMD   48.79 (+2.59%)
T   29.89 (-0.63%)
ACB   0.85 (+6.23%)
F   5.03 (+6.79%)
NFLX   371.12 (-0.31%)
BAC   23.45 (+5.92%)
GILD   74.99 (+0.43%)
DIS   101.07 (-0.17%)
PRI   97.51 (+10.73%)
S&P 500   2,749.98 (+3.41%)
DOW   23,433.57 (+3.44%)
QQQ   200.57 (+2.12%)
AAPL   266.07 (+2.56%)
FB   174.28 (+3.23%)
MSFT   165.13 (+1.00%)
GOOGL   1,207.00 (+2.07%)
AMZN   2,043.00 (+1.56%)
CGC   14.83 (+2.28%)
NVDA   266.95 (+3.06%)
BABA   195.98 (-1.02%)
MU   48.29 (+3.76%)
GE   7.30 (+3.84%)
TSLA   548.84 (+0.62%)
AMD   48.79 (+2.59%)
T   29.89 (-0.63%)
ACB   0.85 (+6.23%)
F   5.03 (+6.79%)
NFLX   371.12 (-0.31%)
BAC   23.45 (+5.92%)
GILD   74.99 (+0.43%)
DIS   101.07 (-0.17%)
PRI   97.51 (+10.73%)
S&P 500   2,749.98 (+3.41%)
DOW   23,433.57 (+3.44%)
QQQ   200.57 (+2.12%)
AAPL   266.07 (+2.56%)
FB   174.28 (+3.23%)
MSFT   165.13 (+1.00%)
GOOGL   1,207.00 (+2.07%)
AMZN   2,043.00 (+1.56%)
CGC   14.83 (+2.28%)
NVDA   266.95 (+3.06%)
BABA   195.98 (-1.02%)
MU   48.29 (+3.76%)
GE   7.30 (+3.84%)
TSLA   548.84 (+0.62%)
AMD   48.79 (+2.59%)
T   29.89 (-0.63%)
ACB   0.85 (+6.23%)
F   5.03 (+6.79%)
NFLX   371.12 (-0.31%)
BAC   23.45 (+5.92%)
GILD   74.99 (+0.43%)
DIS   101.07 (-0.17%)
PRI   97.51 (+10.73%)
S&P 500   2,749.98 (+3.41%)
DOW   23,433.57 (+3.44%)
QQQ   200.57 (+2.12%)
AAPL   266.07 (+2.56%)
FB   174.28 (+3.23%)
MSFT   165.13 (+1.00%)
GOOGL   1,207.00 (+2.07%)
AMZN   2,043.00 (+1.56%)
CGC   14.83 (+2.28%)
NVDA   266.95 (+3.06%)
BABA   195.98 (-1.02%)
MU   48.29 (+3.76%)
GE   7.30 (+3.84%)
TSLA   548.84 (+0.62%)
AMD   48.79 (+2.59%)
T   29.89 (-0.63%)
ACB   0.85 (+6.23%)
F   5.03 (+6.79%)
NFLX   371.12 (-0.31%)
BAC   23.45 (+5.92%)
GILD   74.99 (+0.43%)
DIS   101.07 (-0.17%)
PRI   97.51 (+10.73%)
Log in

ASX:NUCNuchev Stock Price, Forecast & News

A$2.24
-0.03 (-1.32 %)
(As of 04/8/2020 04:00 PM ET)
Add
Compare
Today's Range
A$2.12
Now: A$2.24
A$2.28
50-Day Range
A$1.37
MA: A$2.39
A$3.38
52-Week Range
A$1.37
Now: A$2.24
A$4.17
Volume52,352 shs
Average VolumeN/A
Market Capitalization$100.80 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Nuchev Limited, a health and nutrition solutions company, produces, markets, and sells goat milk based formula and nutritional products to consumers in Australasia. It offers nutritional food; toddler nutrition products; and health and well-being products. The company was founded in 2013 and is headquartered in Melbourne, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars


Industry, Sector and Symbol

Industry Packaged Foods
Sub-IndustryN/A
SectorConsumer Defensive
CUSIPN/A
CIKN/A
Phone61 3 9544 8910

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$15.07 million
Cash FlowA$0.46 per share
Book ValueA$0.63 per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap$100.80 million
Next Earnings DateN/A
OptionableNot Optionable

Receive NUC News and Ratings via Email

Sign-up to receive the latest news and ratings for NUC and its competitors with MarketBeat's FREE daily newsletter.


Nuchev (ASX:NUC) Frequently Asked Questions

How has Nuchev's stock been impacted by COVID-19 (Coronavirus)?

Nuchev's stock was trading at A$2.46 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, NUC stock has decreased by 8.9% and is now trading at A$2.24. View which stocks have been most impacted by Coronavirus.

Has Nuchev been receiving favorable news coverage?

Media stories about NUC stock have been trending very negative this week, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Nuchev earned a news impact score of -3.3 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news aboutNuchev.

Who are some of Nuchev's key competitors?

Who are Nuchev's key executives?

Nuchev's management team includes the following people:
  • Mr. Ben Dingle, Founder, CEO & Exec. Director
  • Mr. Darryl Lasnitzki, Chief Financial Officer
  • Mr. Rhys Denny, Head of Marketing
  • Mr. Ryan Gu, Head of Cross-Border & Export
  • Mr. Doug Sadler, Head of Sales (Australian Retail & Other Markets)

What is Nuchev's stock symbol?

Nuchev trades on the ASX under the ticker symbol "NUC."

What is Nuchev's stock price today?

One share of NUC stock can currently be purchased for approximately A$2.24.

How big of a company is Nuchev?

Nuchev has a market capitalization of $100.80 million and generates $15.07 million in revenue each year.  View additional information about Nuchev.

What is Nuchev's official website?

The official website for Nuchev is http://nuchev.com.au/.

How can I contact Nuchev?

The company can be reached via phone at 61 3 9544 8910.

This page was last updated on 4/8/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel